Table 4.
Correlation with mean platelet volume and type of antidiabetic medication according to multiple linear regression analysis
| Characteristic | Regression coefficient β | SE | 95% CI | P‐value | |
|---|---|---|---|---|---|
| Lower | Upper | ||||
| Sulfonylurea | 0.000 | 0.177 | −0.355 | 0.351 | 0.998 |
| Glinide | −0.438 | 0.498 | −1.429 | 0.553 | 0.377 |
| Metformin | 0.013 | 0.206 | −0.397 | 0.423 | 0.933 |
| Alpha‐glucosidase inhibitor | 0.232 | 0.190 | −0.147 | 0.612 | 0.226 |
| Thiazolidinedione | 0.438 | 0.301 | −0.182 | 1.048 | 0.165 |
| DPP‐4 inhibitor | −0.321 | 0.177 | −0.673 | 0.029 | 0.072 |
| GLP‐1 receptor agonist | −0.471 | 0.717 | −1.898 | 0.957 | 0.514 |
| SGLT‐2 inhibitor | 0.081 | 0.502 | −0.917 | 1.079 | 0.871 |
| Insulin | −0.121 | 0.192 | −0.505 | 0.262 | 0.530 |
CI, confidence interval; DPP‐4, dipeptidyl peptidase; GLP‐1, glucagon‐like peptide‐1; SE, standard error; SGLT‐2, sodium–glucose cotransporter 2.